On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study at the 2025 European Society of Medical Oncology Congress (ESMO 2025) . COMPASSION-15 ...
Due to rising antimicrobial resistance, the treatment of complicated UTIs and acute pyelonephritis is becoming more difficult ...
Median (range) 6.2 (2.3-15.0) 4.5 (2.0-13.7) 4.3 (0.2-14.1) NOTE. Data are No. (%) unless indicated otherwise. The intention-to-treat analysis set included all patients who underwent random assignment ...
Purpose: To assess the safety and efficacy of intensive methotrexate-based chemotherapy followed by high-dose chemotherapy (HDT) with autologous stem-cell rescue in patients with newly diagnosed ...
Standard multidrug therapy for leprosy may be associated with severe side effects, which add to the stigma and discrimination that affect persons with the disease. In addition, the threat posed by ...
For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...
A real-world study of veterans with type 2 diabetes finds better kidney outcomes over 3 years with use of SGLT2i vs GLP1RA. The risk for kidney function decline is lower among new users of sodium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback